PRFX: Rentabilitas operasi PainReform Corp

Tandha merek PainReform (PRFX)

PainReform Ltd. invests in biopolymers to create analgesic delivery systems. Examining the operating margin on GURU.Markets, we see that -16629.00 serves as the current value of the parameter. The company's technology eliminates opioids, addressing the social issues of addiction. Business dynamics rely on the success of clinical trials and the US launch, remaining independent of macroeconomic fluctuations.

PRFX: Rentabilitas dodolan operasi painreform.com 04.07.2022 - 19.11.2026

Rincian metrik lan analitis perusahaan painreform.com (PRFX)

Pambiji fundamental perusahaan:PRFX, PainReform Corp
Barang utama PainReform Ltd.

For the biotechnology company PainReform Ltd. (PRFX), which is in the clinical trial stage without active sales, the operating margin serves as an indicator of the efficiency of managing drug development costs. By analyzing this operating margin chart, an investor assesses the ratio of operating profit to revenue, which, given the issuer's current lack of pricing power, allows for the tracking of the capital burn rate prior to product commercialization.

Analisis perusahaan pesaing

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Telomir Pharma (TELO) - Rentabilitas kegiatan operasi|Rentabilitas operasi Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Tingkat bathi operasi|Rentabilitas operasi Rallybio Corporation RLYB|LEXX: Rentabilitas dodolan miturut bathi operasi|PULM - Rentabilitas operasi|Tingkat bathi operasi PTHL (Pheton Holdings)|Aptorum (APM) - Rentabilitas operasi|LYRA (Lyra Therapeutics) - Rentabilitas operasi|Rentabilitas operasi Impact BioMedical Inc|TNF Pharmaceuticals - Margin bathi operasi|Margin operasi YCBD|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.